OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
May 22, 2015
Appropriate feeding equipment can be selected to meet the challenges of dosing powders that are sticky or do not flow well.
As the biopharma industry awaits FDA’s guidance on biosimilar naming, brand and generic manufacturers establish positions.
May 21, 2015
OXY-CAPT brings together properties of plastic and glass containers through the combination of oxygen absorption and cyclic olefin copolymer (COP) high barrier layers.
Medicago's new production facility will make plant-based vaccines and therapeutics.
CVS Health signed a definitive agreement to acquire Omnicare for $12.7 billion to expand its reach to assisted living and long-term care facilities.
May 20, 2015
Economic benefits, equipment availability, research results, and FDA support are driving progress in continuous processing.
The new guideline replaces the previous version-CHMP/EWP/240/95 Revision 1.
Symbiosis Pharmaceutical Services is now offering a new bulk lyophilization (freeze drying) service in response to increasing demand in the manufacture of bulk intermediates and APIs by lyophilization.
May 19, 2015
Alexion will construct a biologics facility in Ireland that is its first outside the US.
May 15, 2015
This article looks at data gathered from several studies of a widely marketed chlorobutyl rubber formulation used for vial stoppers and prefilled syringes.